GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $75,000 | 0.0% | 1,724 | 0.0% | 0.05% | +13.3% |
| Q1 2022 | $75,000 | -1.3% | 1,724 | 0.0% | 0.04% | -2.2% |
| Q4 2021 | $76,000 | +15.2% | 1,724 | 0.0% | 0.05% | +4.5% |
| Q3 2021 | $66,000 | -4.3% | 1,724 | 0.0% | 0.04% | -6.4% |
| Q2 2021 | $69,000 | +11.3% | 1,724 | 0.0% | 0.05% | 0.0% |
| Q1 2021 | $62,000 | -3.1% | 1,724 | 0.0% | 0.05% | -14.5% |
| Q4 2020 | $64,000 | -9.9% | 1,724 | -8.7% | 0.06% | -19.1% |
| Q3 2020 | $71,000 | -38.8% | 1,888 | -33.6% | 0.07% | -45.6% |
| Q2 2020 | $116,000 | +7.4% | 2,845 | 0.0% | 0.12% | -8.1% |
| Q1 2020 | $108,000 | -19.4% | 2,845 | 0.0% | 0.14% | +2.3% |
| Q4 2019 | $134,000 | +13.6% | 2,845 | 0.0% | 0.13% | +17.7% |
| Q3 2019 | $118,000 | +0.9% | 2,845 | 0.0% | 0.11% | +2.7% |
| Q2 2019 | $117,000 | -29.9% | 2,845 | -28.7% | 0.11% | -31.2% |
| Q1 2019 | $167,000 | +6.4% | 3,992 | 0.0% | 0.16% | +4.6% |
| Q4 2018 | $157,000 | – | 3,992 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |